Kilitch Drugs (India) consolidated net profit rises 126.12% in the June 2025 quarter
Sales rise 28.97% to Rs 43.14 crore
Net profit of Kilitch Drugs (India) rose 126.12% to Rs 3.03 crore in the quarter ended June 2025 as against Rs 1.34 crore during the previous quarter ended June 2024. Sales rose 28.97% to Rs 43.14 crore in the quarter ended June 2025 as against Rs 33.45 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales43.1433.45 29 OPM %7.564.96 -PBDT4.292.50 72 PBT3.451.65 109 NP3.031.34 126Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 14 2025 | 7:37 AM IST